Neurology® Podcast

Dr. Gordon Smith talks with Prof. Mike Lunn about the relationship between COVID-19 vaccinations and Guillain-Barré syndrome using the National Immunoglobulin Database.

Read the related article in Brain.

Disclosures can be found at Neurology.org.

Dr. Derek Stitt talks with Dr. Ali A. Habib about trends in hospital admissions and in-hospital mortality for adult patients with MG.

Read the related article in Neurology®.

Disclosures can be found at Neurology.org.

Dr. Jason Crowell talks with Dr. Benjamin N. Rome about ways to improve pharmacy benefit managers and the way they function in the system.

Read the related article in The New England Journal of Medicine.

Referenced in this Episode:

June 2021 Neurology Recall Episode

Disclosures can be found at Neurology.org.

Dr. Gordon Smith talks with Dr. Haya Bishara about the association between GBS and both SARS-CoV-2 infection and the COVID-19 vaccine.

Read the related article in Neurology.

Disclosures can be found at Neurology.org.

The January 2024 replay starts the new year off with four previously posted episodes on dementia. The episode begins with an interview with Dr. Kenneth Langa on the prevalence of dementia and mild cognitive impairment in the US. The episode continues with an interview with Dr. Beau Ances about the burden amyloid has on individuals with Down syndrome compared to autosomal dominant Alzheimer disease. The next interview is with Dr. Erik Musiek on the use of lecanemab in early Alzheimer disease. The fourth and final interview is with Dr. Vijay Ramanan on the eligibility for anti-amyloid treatment.

Related Podcast Links:

Estimating the Prevalence of Dementia and Mild Cognitive Impairment in the United States: https://directory.libsyn.com/episode/index/id/25811241

Comparison of Amyloid Burden in Individuals with Down Syndrome Versus Autosomal Dominant Alzheimer Disease: https://directory.libsyn.com/episode/index/id/25881414

Lecanemab in Early Alzheimer Disease: https://directory.libsyn.com/episode/index/id/25428333

Eligibility for Anti-Amyloid Treatment: https://directory.libsyn.com/episode/index/id/28300052

Related Article Links:

Estimating the Prevalence of Dementia and Mild Cognitive Impairment in the US: https://jamanetwork.com/journals/jamaneurology/article-abstract/2797274?resultClick=1

Comparison of Amyloid Burden in Individuals with Down Syndrome Versus Autosomal Dominant Alzheimer's Disease: A Cross-Sectional Study: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(22)00408-2/fulltext

Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging: https://www.neurology.org/doi/10.1212/WNL.0000000000207770

Disclosures can be found at Neurology.org

Dr. Jeff Ratliff talks with Drs. Divya Singhal and Myriam Abdennadher about work-life, parenting, and the well-being of neurologists during the COVID-19 pandemic.

Read the related article in Neurology: Clinical Practice.

Disclosures can be found at Neurology.org.

Dr. Andrew Southerland talks with Dr. Franzi Herpich about her journey of experiencing a stroke in 2021 as part of our physician-as-patient series.

Previously Posted Content:

April 2022 Neurology Recall: Physician as Patient

Disclosures can be found at Neurology.org.

Dr. Adam de Havenon talks with Dr. Gustaf Edgren about the potential transmissible risk associated with some types of spontaneous intracerebral hemorrhage in patients who receive transfusions.

Read the related article in JAMA.

Disclosures can be found at Neurology.org.

Dr. Elizabeth Coon talks with Dr. Mitchell G. Miglis about the frequency of orthostatic hypotension in isolated REM sleep behavior disorder.

Read the related article in Neurology.

Disclosures can be found at Neurology.org.

Dr. Jeff Ratliff talks with Drs. Michael Fox and Jacob Stubbs about their study on brain network associations in substance use disorders.

Read the related article in Nature.

Disclosures can be found at Neurology.org.